The largest database of trusted experimental protocols

9 protocols using pamidronate

1

Gal-1 Knockout Bone Marrow Transplant

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 wild-type were bred at our animal facility. Gal-1 knock-out (Lgals1−/−) mice were a gift from Dr. Françoise Poirier (Institut Jacques Monod, Université Paris Diderot, Paris, France). Both strains were kept in specific pathogen-free conditions and water was supplied ad libitum. All animal procedures were approved by the ethical committee. Ethical committee name: Commission Ethique Animale—Université de Liège; approval code: # 14-1635 (given on 24 December 2014). Prior to bone marrow transplantation, eight to twelve-week mice were irradiated at 6Gy. Two hours post-irradiation, 2 × 106 bone marrow cells from syngeneic mice were injected via tail vein injection. Hematopoietic stem cells from gal-1−/− mice were injected in recipient gal-1−/− and hematopoietic stem cells from WT mice injected in WT mice. 24 h after transplantation, 2 × 106 5TGM.1 GFP+ cells were inoculated intravenously. During the experiments with bisphosphonates, mice received either PBS (control group; Lonza) or 1.5 mg/kg pamidronate (Sigma-Aldrich) subcutaneously once per week. Bone marrow infiltration of MM cells in mice was determined by FACS detection of GFP+ cells on a FACSCantoII flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). All experimental procedures were approved by the University of Liege (Liège, Belgium) Ethical Committee.
+ Open protocol
+ Expand
2

Human pol β purification and assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human pol β was expressed and purified44 (link). Chlodronate, etidronate, imidodiphosphate, pamidronate, and pyrophosphate were from Sigma-Aldrich. The β,γ-imido modified nucleoside triphosphate analog, 2′-deoxyguanosine-5′-[(β,γ)-imido]triphosphate (dGMPPNP), was from Jena Bioscience. Chain terminating nucleoside triphosphates; ddCTP was from GE Healthcare, 3′-azido-2′,3′-dideoxythymidine triphosphate (AZTTP) and arabinofuranosylcytosine triphosphate (araCTP) were from Trilink Biotechnologies, and gemcitabine (dFdCTP) was obtained from Jena Bioscience. [α-35S]dATP, [α-32P]dCTP, and [32P]PPi were from Perkin Elmer. Polyethyleneimine (PEI) cellulose thin layer chromatography (TLC) plates containing a fluorescent indicator were purchased from EMD Millipore.
+ Open protocol
+ Expand
3

Chronic Pamidronate Treatment in OVX Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 72 h after the last acute treatment, mice (OVX, n = 22; sham-operated, n = 28; 6 months after surgery) were randomly reassigned to receive chronic treatment with either pamidronate (0.25 mg/kg, i.p., Sigma-Aldrich, St. Louis, MO) or a saline vehicle control. The drug or saline was administered 5 days/week for 5 weeks. pamidronate belongs to the bisphosphonate class of medications commonly administered to patients with osteoporosis or bone metastasis. BMDs and behavioral signs were measured prior to each daily drug/vehicle administration to avoid acute effects or interactions with the anesthetic cocktail. Although chronic pamidronate treatment was the last intervention tested in this study, it is presented first in the results for clarity.
+ Open protocol
+ Expand
4

Osteogenic Differentiation Assay Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following were purchased from ThermoFisher Scientific (Carlsbad, CA, USA): MEMα with or without phenol red; MEMα with or without ascorbic acid (vitamin C); MEMα with or without calcium (Ca2+); penicillin/streptomycin; L-glutamine; TaqMan gene expression assays for ALPG (Hs00741068_g1), ALPI (Hs00357579_g1), ALPL (Hs10129144_m1), ALPP (Hs00740632_gH), GAPDH (Hs99999905_m1); universal PCR master mix. Recombinant human ALPL was purchased from R&D Systems (Minneapolis, MN, USA). Rabbit anti-human ALPL antibody, calf intestinal ALP (CIP, ≥10 DEA U/mg), disodium β-glycerophosphate (βGP), phospho(enol)pyruvate monosodium (PEP), pamidronate, dexamethasone, and Alizarin Red S solution were purchased from Sigma-Aldrich (St. Louis, MO, USA). CIP (≥10,000 U/mL), shrimp hepatopancreas ALP (≥1000 unit/mL), and p-nitrophenyl phosphate kits were purchased from New England BioLabs (Ipswich, MA, USA). FBS was purchased from Atlanta Biologicals (Flowery Branch, GA, USA). Disodium α-glycerophosphate hydrate (1 M of αGP; Glycophos) was purchased from Fresenius Kabi (Lake Zurich, IL, USA), and glycerophosphoric acid (NSC 9231) was obtained from the Developmental Therapeutics Program (NCI, USA). Collagen Type I, rat tail, stock solution was obtained from BD Biosciences Discovery Labware (Waltham, MA, USA).
+ Open protocol
+ Expand
5

Feline OSCC and Fibrosarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
A feline OSCC cell line (SCCF1, provided by Dr. Thomas J. Rosol, The Ohio State University) was grown in Williams E media supplemented with 2 mM l-glutamine, 0.05 mg/mL gentamicin, 10 ng/mL epidermal growth factor, 0.01 nM cholera toxin, and 10% fetal bovine serum (FBS). A feline fibrosarcoma (FSA) cell line (FC83, purchased from ATCC) was grown in DMEM supplemented with 10% FBS. Cell cultures were maintained in subconfluent monolayers at 37°C in a 5% CO2 humidified chamber and passaged twice weekly. Pamidronate was purchased from Sigma-Aldrich (St. Louis, MO) and stock solutions (1 mg/mL) were prepared in sterile phosphate-buffered saline (PBS), aliquoted, and frozen at −20°C until use. Cells were cultured in media as described above for controls; no vehicle control was necessary given use of PBS as Pamidronate drug vehicle.
+ Open protocol
+ Expand
6

Human pol β purification and assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human pol β was expressed and purified44 (link). Chlodronate, etidronate, imidodiphosphate, pamidronate, and pyrophosphate were from Sigma-Aldrich. The β,γ-imido modified nucleoside triphosphate analog, 2′-deoxyguanosine-5′-[(β,γ)-imido]triphosphate (dGMPPNP), was from Jena Bioscience. Chain terminating nucleoside triphosphates; ddCTP was from GE Healthcare, 3′-azido-2′,3′-dideoxythymidine triphosphate (AZTTP) and arabinofuranosylcytosine triphosphate (araCTP) were from Trilink Biotechnologies, and gemcitabine (dFdCTP) was obtained from Jena Bioscience. [α-35S]dATP, [α-32P]dCTP, and [32P]PPi were from Perkin Elmer. Polyethyleneimine (PEI) cellulose thin layer chromatography (TLC) plates containing a fluorescent indicator were purchased from EMD Millipore.
+ Open protocol
+ Expand
7

Bisphosphonate Preparation and Use

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zoledronate used in in vitro experiments was kindly provided by Novartis Pharma (Basel, Switzerland). Clodronate, Pamidronate, Ibandronate were purchased from Sigma Aldrich (St. Louis, MO, USA), as well as Zoledronate used in in vivo studies. The structure of bisphosphonates is depicted in Figure 1. Bisphosphonate stock solutions were prepared in distilled water, adjusted to pH 7.4 and filter-sterilized prior to use. Empty liposomes and Clodrolip were prepared as described before [43] (link). Other reagents were purchased from Sigma Aldrich. All solutions were prepared in distilled water and filter-sterilized prior to use.
+ Open protocol
+ Expand
8

Synthesis of NIR Fluorescent Gold Nanocluster-Pamidronate Probe

Check if the same lab product or an alternative is used in the 5 most similar protocols
A gold nanocluster-based Pamidronate NIR fluorescent probe was synthesized according to the methods in our other studies [37 (link),38 ,39 ]. Briefly, fluorescent gold nanoclusters were synthesized using nanoparticle-etching methods. Pamidronate was attached to the carboxylated surface of a nanocluster using an N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) (Sigma-Aldrich, St. Louis, MO, USA) crosslinker. Briefly, nano-Au-Pam (em 674 nm) was synthesized by immobilizing Pamidronate (Sigma 2371) onto nano-Au particles using a zero-length crosslinking agent, 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC). To link the Pamidronate to nano-Au particles, equal volumes of Au nanoclusters (40 mM), Pamidronate (3 mM), and EDC (80 mM) were mixed at room temperature for 2 h for the crosslinking reaction. To concentrate the conjugated nano-Au-Pam, the reaction solution was loaded in a 30-kDa molecular sieve (Amicon, Millipore, Bedford, MA, USA) and centrifuged to concentrate the conjugated nano-Au-Pam at 3000 rpm for 10 min. The solution was centrifuged twice and washed with phosphate-buffered saline (PBS) (Sigma-Aldrich, MO, USA) to remove any unbound reactants.
+ Open protocol
+ Expand
9

Osteogenic Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following were purchased from ThermoFisher Scientific (Carlsbad, CA, USA): MEMα with or without phenol red; MEMα with or without ascorbic acid (vitamin C); MEMα with or without calcium (Ca 2+ ); penicillin/streptomycin; L-glutamine; TaqMan gene expression assays for ALPG (Hs00741068_g1), ALPI (Hs00357579_g1), ALPL (Hs10129144_m1), ALPP (Hs00740632_gH), GAPDH (Hs99999905_m1); universal PCR master mix. Recombinant human ALPL was purchased from R&D Systems (Minneapolis, MN, USA). Rabbit anti-human ALPL antibody, calf intestinal ALP (CIP, ≥10 DEA U/mg), disodium β-glycerophosphate (βGP), phospho(enol)pyruvate monosodium (PEP), pamidronate, dexamethasone, and Alizarin Red S solution were purchased from Sigma-Aldrich (St. Louis, MO, USA). CIP (≥10,000 U/mL), shrimp hepatopancreas ALP (≥1000 unit/mL), and p-nitrophenyl phosphate kits were purchased from New England BioLabs (Ipswich, MA, USA). FBS was purchased from Atlanta Biologicals (Flowery Branch, GA, USA). Disodium α-glycerophosphate hydrate (1 M of αGP; Glycophos) was purchased from Fresenius Kabi (Lake Zurich, IL, USA), and glycerophosphoric acid (NSC 9231) was obtained from the Developmental Therapeutics Program (NCI, USA). Collagen Type I, rat tail, stock solution was obtained from BD Biosciences Discovery Labware (Waltham, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!